Home / Companies / Protagonist Therapeutics, Inc. / 20 Jun 2025
Protagonist Therapeutics, Inc.: meeting of 20 Jun 2025
Votes reported on Form N-PX, item by item
409 Form N-PX filers reported votes at the Protagonist Therapeutics, Inc. meeting of 20 Jun 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 47.3% of reported votes for; 97 filers withheld from or voted against at least one nominee.
546 vote records from 144 filers. 70 of the 144 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
579 vote records from 404 filers. 55 of the 396 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
274 vote records from 144 filers. 5 of the 144 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | For | For |
| Fidelity | For | For | For |
| Dimensional | No report | For | No report |
| State Street and SPDR | For | For | For |
| American Century | Abstain or withhold * | Against * | For |
| Franklin Templeton | For | For | For |
| Invesco | Split or no vote | Against * | For |
| Equitable | For | For | For |
| Charles Schwab | Split or no vote | For | For |
| Nuveen and TIAA | Abstain or withhold * | For | For |
| ProShares and ProFunds | Abstain or withhold * | For | For |
| John Hancock and Manulife | For | For | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | For |
| J.P. Morgan | For | For | For |
| Goldman Sachs | Abstain or withhold * | For | For |
| WisdomTree | Abstain or withhold * | For | For |
| PGIM and Prudential | For | For | For |
| Jackson National funds | Abstain or withhold * | For | For |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | Split or no vote | For | For |
| T. Rowe Price | For | For | For |
| Thrivent | Abstain or withhold * | For | For |
| Lincoln Financial | For | For | For |
| Voya | Split or no vote | For | For |
| First Trust | Abstain or withhold * | For | For |
| Russell Investments | No report | For | No report |
| Nationwide | For | For | For |
| Victory Capital | Abstain or withhold * | For | For |
| Brighthouse Funds | Abstain or withhold * | For | For |
| Guggenheim and Rydex | Abstain or withhold * | For | For |
| Columbia Threadneedle | Split or no vote | For | For |
| BNY Mellon | Abstain or withhold * | For | For |
| Principal | Abstain or withhold * | For | For |
| Pacific Life funds | For | For | For |
| Global X | Split or no vote | For | For |
| MFS | Abstain or withhold * | For | For |
| AllianceBernstein | No report | For | No report |
| Hartford Funds | For | For | For |
| DWS | Abstain or withhold * | For | For |
| MassMutual | For | For | For |
| Neuberger Berman | No report | For | No report |
| Natixis and Loomis Sayles | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Protagonist Therapeutics, Inc. meeting?
409 Form N-PX filers reported votes at the meeting of 20 Jun 2025. On say-on-pay, 55 of 396 voted against management (13.9%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Protagonist Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Protagonist Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Protagonist Therapeutics, Inc. with a meeting date within three days of 20 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.